Citadel Advisors’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History

Citadel Advisors’s Portfolio PILL Stock Details PILL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,978	Closed	-$277K	–	10018
2019 Q4	$277K	Buy	+10,978	New	+$187K	﹤0.01%	7708

Other funds holding PILL

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Manchester Financial Westlake Village, California $563M AUM 21.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors's PILL Position: Q1 2020 in Review

Citadel Advisors sold out of Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) in Q1 2020, closing a stake of 10,978 shares — an estimated $277K sold.

Citadel Advisors first reported a position in PILL in Q4 2019 and held it in 1 quarter. The position peaked at $277K in Q4 2019. 4 funds tracked by Wall St. Rank hold PILL as of Q1 2020.

Citadel Advisors reported no remaining Direxion Daily Pharmaceutical & Medical Bull 3X ETF position as of Q1 2020 after selling out during the quarter.
Citadel Advisors sold 10,978 Direxion Daily Pharmaceutical & Medical Bull 3X ETF shares in Q1 2020, an estimated $277K.
Citadel Advisors first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q4 2019 and held it in 1 quarter.
Citadel Advisors's Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $277K in Q4 2019.
4 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q1 2020.

Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.